At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
neuromodulation for episodic migraine headachedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
In Brief
A clinical study evaluating neuromodulation for episodic migraine headache for Migraine Headache, Episodic. Completed, enrolled 100 participants across 6 sites in 2 countries.
Detailed Summary
This is a randomized, blinded study designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of episodic migraine headaches.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine Headache, Episodic
CountriesUnited Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 2013
Enrollment StartAug 2013
Primary CompletionMay 2016
Study CompletionJun 2016
TodayJul 2026
First PostedJul 15, 2013
Enrollment StartAug 1, 2013
Primary CompletionMay 1, 2016
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 13.0 years ago
Interventions
neuromodulation for episodic migraine headachedevice